Your browser doesn't support javascript.
loading
Evaluation of epiandrosterone as a long-term marker of testosterone use.
Nair, Vinod S; Doman, Christine E; Morrison, Matthew S; Miller, Geoffrey D; Husk, Jacob; van Eenoo, Peter; Crouch, Andre K; Eichner, Daniel.
Affiliation
  • Nair VS; Sports Medicine Research and Testing Laboratory, South Jordan, UT, USA.
  • Doman CE; Sports Medicine Research and Testing Laboratory, South Jordan, UT, USA.
  • Morrison MS; Sports Medicine Research and Testing Laboratory, South Jordan, UT, USA.
  • Miller GD; Sports Medicine Research and Testing Laboratory, South Jordan, UT, USA.
  • Husk J; Sports Medicine Research and Testing Laboratory, South Jordan, UT, USA.
  • van Eenoo P; DoCoLab, Department of Chemical Biology, Microbiology and Immunology, Ghent University, Ghent, Belgium.
  • Crouch AK; Sports Medicine Research and Testing Laboratory, South Jordan, UT, USA.
  • Eichner D; Sports Medicine Research and Testing Laboratory, South Jordan, UT, USA.
Drug Test Anal ; 12(11-12): 1554-1560, 2020 Nov.
Article in En | MEDLINE | ID: mdl-32697436
ABSTRACT
Identification and evaluation of long-term markers is crucial in prolonging the detection window for anabolic steroid abuse in sport. Recently, sulfoconjugated epiandrosterone was identified as a potential long-term marker for the abuse of certain endogenous anabolic agents, including testosterone, which continues to be widely used as a performance enhancing agent in sport. To evaluate the applicability of epiandrosterone sulfate as a marker for testosterone use, administration studies were conducted with multiple modes of testosterone administration - transdermal, intramuscular, and subcutaneous. A modified sample preparation method was used to collect both glucuronidated and sulfoconjugated analytes of interest. Carbon isotope ratio measurements from the administration studies are presented here. Epiandrosterone was less effective than the conventionally used target compounds for detection of the low dose application (transdermal gel). With intramuscular administration, epiandrosterone was more diagnostic than with transdermal administration, but it did not prolong the detection window more than the conventional target compounds. With subcutaneous administration, the doses administered to the subjects were varied and the effect on the epiandrosterone values was dependent on the magnitude of the dose administered. Epiandrosterone does not appear to be a useful marker in the detection of low dose testosterone administration. It is responsive to higher dose administration, but it does not provide an extension of the detection window relative to conventional target compounds.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Testosterone / Substance Abuse Detection / Anabolic Agents / Androsterone Type of study: Prognostic_studies Limits: Adult / Humans / Male Language: En Journal: Drug Test Anal Journal subject: FARMACOLOGIA Year: 2020 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Testosterone / Substance Abuse Detection / Anabolic Agents / Androsterone Type of study: Prognostic_studies Limits: Adult / Humans / Male Language: En Journal: Drug Test Anal Journal subject: FARMACOLOGIA Year: 2020 Document type: Article Affiliation country: United States